TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Glioma Diagnosis and Treatment Market, by Type
6.1 Introduction
6.2 Primary Tumor
6.2.1 Market Estimates & Forecast, 2023-2032
6.2.2 Ependymomas
6.2.2.1 Market Estimates & Forecast, 2023-2032
6.2.2.2 Subependymomas (grade i)
6.2.2.2.1 Market Estimates & Forecast, 2023-2032
6.2.2.3 Myxopapillary Ependymomas (grade i)
6.2.2.3.1 Market Estimates & Forecast, 2023-2032
6.2.2.4 Ependymomas (grade ii)
6.2.2.4.1 Market Estimates & Forecast, 2023-2032
6.2.2.5 Anaplastic Ependymomas (grade iii)
6.2.2.5.1 Market Estimates & Forecast, 2023-2032
6.2.3 Astrocytomas
6.2.3.1 Market Estimates & Forecast, 2023-2032
6.2.3.2 Anaplastic Astrocytomas
6.2.3.2.1 Market Estimates & Forecast, 2023-2032
6.2.3.3 Glioblastoma Multiforme
6.2.3.3.1 Market Estimates & Forecast, 2023-2032
6.2.3.4 Benign Astrocytomas
6.2.3.4.1 Market Estimates & Forecast, 2023-2032
6.2.4 Oligodendrogliomas
6.2.4.1 Market Estimates & Forecast, 2023-2032
6.2.5 Brainstem Glioma
6.2.5.1 Market Estimates & Forecast, 2023-2032
6.2.6 Optic Nerve Glioma
6.2.6.1 Market Estimates & Forecast, 2023-2032
6.2.6.2 Malignant Optic Nerve Glioma
6.2.6.2.1 Market Estimates & Forecast, 2023-2032
6.2.6.3 Benign Optic Nerve Glioma
6.2.6.3.1 Market Estimates & Forecast, 2023-2032
6.2.7 Mixed Gliomas
6.2.7.1 Market Estimates & Forecast, 2023-2032
6.2.7.2 Oligoastrocytomas
6.2.7.2.1 Market Estimates & Forecast, 2023-2032
6.2.7.3 Others
6.3 Secondary Tumor
6.3.1 Market Estimates & Forecast, 2023-2032
Chapter 7. Global Glioma Diagnosis and Treatment Market, by Diagnosis
7.1 Introduction
7.2 Neurological Exam
7.2.1 Market Estimates & Forecast, 2023-2032
7.3 Computed Tomography (CT) scan
7.3.1 Market Estimates & Forecast, 2023-2032
7.4 Magnetic Resonance Imaging (MRI)
7.4.1 Market Estimates & Forecast, 2023-2032
7.5 Radionuclide Imaging
7.5.1 Market Estimates & Forecast, 2023-2032
7.6 Position Emission Tomography (PET) Scan
7.6.1 Market Estimates & Forecast, 2023-2032
7.7 Biopsy
7.7.1 Market Estimates & Forecast, 2023-2032
7.8 Molecular Testing
7.8.1 Market Estimates & Forecast, 2023-2032
7.9 Electroencephalography (EEG)
7.9.1 Market Estimates & Forecast, 2023-2032
7.10 Others
Chapter 8. Global Glioma Diagnosis and Treatment Market, by Treatment
8.1 Introduction
8.2 Surgery
8.2.1 Market Estimates & Forecast, 2023-2032
8.2.2 Open Heart Surgery
8.2.2.1 Market Estimates & Forecast, 2023-2032
8.2.3 Minimal Invasive Surgery
8.2.3.1 Market Estimates & Forecast, 2023-2032
8.3 Chemotherapy
8.3.1 Market Estimates & Forecast, 2023-2032
8.4 Radiation Therapy
8.4.1 Market Estimates & Forecast, 2023-2032
8.5 Immunotherapy
8.5.1 Market Estimates & Forecast, 2023-2032
8.6 Targeted Therapy
8.6.1 Market Estimates & Forecast, 2023-2032
Chapter 9. Global Glioma Diagnosis and Treatment Market, by Grade
9.1 Introduction
9.2 Low-Grade Gliomas
9.2.1 Market Estimates & Forecast, 2023-2032
9.3 High-Grade Gliomas
9.3.1 Market Estimates & Forecast, 2023-2032
9.4 Recurrent High-Grade Glioma
9.4.1 Market Estimates & Forecast, 2023-2032
Chapter 10. Global Glioma Diagnosis and Treatment Market, by Location
10.1 Introduction
10.2 Supratentorial
10.2.1 Market Estimates & Forecast, 2023-2032
10.3 Infratentorial
10.3.1 Market Estimates & Forecast, 2023-2032
Chapter 11. Global Glioma Diagnosis and Treatment Market, by End-U.S.er
11.1 Introduction
11.2 Hospitals & Clinics
11.2.1 Market Estimates & Forecast, 2023-2032
11.3 Diagnostic Centers
11.3.1 Market Estimates & Forecast, 2023-2032
11.4 Medical Research Centers
11.4.1 Market Estimates & Forecast, 2023-2032
11.5 Others
Chapter .12 Global Glioma Diagnosis and Treatment Market, by Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.1.1 U.S.
12.2.1.1 Canada
12.2.2 South America
12.3 Europe
12.3.1 Western Europe
12.3.1.1 Germany
12.3.1.2 France
12.3.1.3 Italy
12.3.1.4 Spain
12.3.1.5 U.K.
12.3.1.6 Rest of Western Europe
12.3.2 Eastern Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 Republic of Korea
12.4.6 Rest of Asia Pacific
12.5 The Middle East & Africa
12.5.1 United Arab Emirates
12.5.2 Saudi Arabia
12.5.3 Oman
12.5.4 Kuwait
12.5.5 Qatar
12.5.6 Rest of the Middle East & Africa
Chapter 13 Company Landscape
13.1 Introduction
13.2 Market Share Analysis
13.3 Key Development & Strategies
13.3.1 Key Developments
Chapter 14 Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Company Overview
14.1.2 Product Overview
14.1.3 Financials
14.1.4 SWOT Analysis
14.2 Emcure Pharmaceuticals Ltd.
14.2.1 Company Overview
14.2.2 Product Overview
14.2.3 Financial Overview
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.3 Pfizer Inc.
14.3.1 Company Overview
14.3.2 Product Overview
14.3.3 Financial Overview
14.3.4 Key Development
14.3.5 SWOT Analysis
14.4 Novartis International AG
14.4.1 Company Overview
14.4.2 Product/Business Segment Overview
14.4.3 Financial Overview
14.4.4 Key Development
14.4.5 SWOT Analysis
14.5 Teva Pharmaceutical Industries Ltd.
14.5.1 Company Overview
14.5.2 Product Overview
14.5.3 Financial overview
14.5.4 Key Developments
14.6 Shimadzu Corporation
14.6.1 Company Overview
14.6.2 Product Overview
14.6.3 Financial Overview
14.6.4 Key Developments
14.7 GE Healthcare
14.7.1 Overview
14.7.2 Product Overview
14.7.3 Financials
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.8 Siemens Healthineers
14.8.1 Company Overview
14.8.2 Product/Business Segment Overview
14.8.3 Financial Overview
14.8.4 Key Development
14.8.5 SWOT Analysis
14.9 Toshiba Medical Systems Corporation
14.9.1 Company Overview
14.9.2 Product Overview
14.9.3 Financial overview
14.9.4 Key Developments
14.10 Others
Chapter 15 MRFR Conclusion
15.1 Key Findings
15.1.1 From CEO’s View Point
15.1.2 Unmet Needs of the Market
15.2 Key Companies to Watch
15.3 Prediction of Pharmaceutical Industry
Chapter 16 Appendix
LIST OF TABLES
Table 1 Glioma Diagnosis and Treatment Industry Synopsis, 2023-2032
Table 2 Glioma Diagnosis and Treatment Market Estimates and Forecast, 2023-2032, (USD Million)
Table 3 Glioma Diagnosis and Treatment Market, by Region, 2023-2032, (USD Million)
Table 4 Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 5 Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 6 Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 7 North America glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 8 North America Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 9 North America Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 10 U.S. Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 11 U.S. Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 12 U.S. Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 13 Canada Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 14 Canada Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 15 Canada Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 16 South America Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 17 South America Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 18 South America Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 19 Europe Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 20 Europe Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 21 Europe Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 22 Western Europe Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 23 Western Europe Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 24 Western Europe Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 25 Eastern Europe Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 26 Eastern Europe Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 27 Eastern Europe Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 28 Asia Pacific Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 29 Asia Pacific Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 30 Asia Pacific Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
Table 31 Middle East & Africa Glioma Diagnosis and Treatment Market, by Type, 2023-2032, (USD Million)
Table 32 Middle East & Africa Glioma Diagnosis and Treatment Market, by Diagnosis, 2023-2032, (USD Million)
Table 33 Middle East & Africa Glioma Diagnosis and Treatment Market, by Treatment, 2023-2032, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Glioma Diagnosis and Treatment Market
Figure 3 Segmentation Market Dynamics for Glioma Diagnosis and Treatment Market
Figure 4 Global Glioma Diagnosis and Treatment Market Share, by Type 2020
Figure 5 Global Glioma Diagnosis and Treatment Market Share, by Diagnosis 2020
Figure 6 Global Glioma Diagnosis and Treatment Market Share, by Treatment, 2020
Figure 7 Global Glioma Diagnosis and Treatment Market Share, by Region, 2020
Figure 8 North America Glioma Diagnosis and Treatment Market Share, by Country, 2020
Figure 9 Europe Glioma Diagnosis and Treatment Market Share, by Country, 2020
Figure 10 Asia Pacific Glioma Diagnosis and Treatment Market Share, by Country, 2020
Figure 11 Middle East & Africa Glioma Diagnosis and Treatment Market Share, by Country, 2020
Figure 12 Global Glioma Diagnosis and Treatment Market: Company Share Analysis, 2020 (%)
Figure 13 THERMO FISHER SCIENTIFIC INC.: Key Financials
Figure 14 THERMO FISHER SCIENTIFIC INC.: Segmental Revenue
Figure 15 THERMO FISHER SCIENTIFIC INC.: Geographical Revenue
Figure 16 Emcure Pharmaceuticals Ltd.: Key Financials
Figure 17 Emcure Pharmaceuticals Ltd.: Segmental Revenue
Figure 18 Emcure Pharmaceuticals Ltd.: Geographical Revenue
Figure 19 Pfizer Inc.: Key Financials
Figure 20 Pfizer Inc.: Segmental Revenue
Figure 21 Pfizer Inc.: Geographical Revenue
Figure 22 Novartis International AG: Key Financials
Figure 23 Novartis International AG: Segmental Revenue
Figure 24 Novartis International AG: Geographical Revenue
Figure 25 Teva Pharmaceutical Industries Ltd.: Key Financials
Figure 26 Teva Pharmaceutical Industries Ltd.: Segmental Revenue
Figure 27 Teva Pharmaceutical Industries Ltd.: Geographical Revenue
Figure 28 Shimadzu Corporation.: Key Financials
Figure 29 Shimadzu Corporation: Segmental Revenue
Figure 30 Shimadzu Corporation: Geographical Revenue
Figure 31 GE Healthcare: Key Financials
Figure 32 GE Healthcare: Segmental Revenue
Figure 33 GE Healthcare: Geographical Revenue
Figure 34 Siemens Healthineers: Key Financials
Figure 35 Siemens Healthineers: Segmental Revenue
Figure 36 Siemens Healthineers: Geographical Revenue
Figure 37 Toshiba Medical Systems Corporation: Key Financials
Figure 38 Toshiba Medical Systems Corporation: Segmental Revenue
Figure 39 Toshiba Medical Systems Corporation: Geographical Revenue
